Actual Medicinal Product (AMP) Zemplar 2microgram capsules (AbbVie Ltd)

Stability Information

(Some stability information inherited from generic)

Stability: Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes: Store in airtight containers.
Provenance: Compatibility recommendation derived from Zemplar 2microgram capulsts (AbbVie Ltd).
Generic: Paricalcitol
Formulation: Paricalcitol 2microgram capsules

Paricalcitol
- Paricalcitol 2microgram capsules
  - Zemplar 2microgram capsules (AbbVie Ltd)